Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Mesenchymal Stem Cells in a Clinical Trial to Heal Articular Cartilage Defects

This study is ongoing, but not recruiting participants.
Information provided by (Responsible Party):
Asbjorn Aroen, University Hospital, Akershus Identifier:
First received: April 17, 2009
Last updated: October 14, 2015
Last verified: October 2015